Table 3.
Successful Opioid Use Outcome by the Phase 2 Period
| Phase 2 period | Observed % (n) | [95% CI] | GLMM model-based results | |
|---|---|---|---|---|
| OR [95% CI] | p value | |||
| End of treatment | 49.2 (177/360) | [43.9,54.5] | 10.6b [7.2,15.6] | <0.001 |
| 8-week post-treatment follow-up | 8.6 (31/360) | [5.9,12.0] | ||
CI = Confidence Interval; OR = Odds Ratio; GLMM = generalized linear mixed model
Reference category = 8-week post-treatment follow-up